PT  - JOURNAL ARTICLE
AU  - F Cuculi
AU  - C C S Lim
AU  - A P Banning
TI  - Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented?
AID  - 10.1136/hrt.2009.186189
DP  - 2010 May 01
TA  - Heart
PG  - 736--740
VI  - 96
IP  - 10
4099  - http://heart.bmj.com/content/96/10/736.short
4100  - http://heart.bmj.com/content/96/10/736.full
SO  - Heart2010 May 01; 96
AB  - Periprocedural myocardial injury (PMI) is common after percutaneous coronary intervention (PCI). Periprocedural infarction (myocardial infarction type 4a) occurs after at least 10% of PCI procedures and has an impact on long-term prognosis. Measurement of biomarkers to allow assessment of PMI is an important tool for clinical and research purposes and should be routine after every PCI (troponin I or T and CK-MB). The importance of oral and intravenous antiplatelet agents and other drugs which have been proven to reduce PMI is discussed.